Docs Cool to Wide Distribution of PrEP

Despite initial positive reaction to the pill Truvada, which looked to be a way to hinder HIV infection, doctors now say they are hesitant to prescribe the expensive drug to otherwise healthy people because it might cause severe nausea and kidney damage.

Bloomberg News reports that while the breakthrough was significant for those looking to prevent HIV transmission or slow down its manifestation, the drug is costly (about $12,000 annually or $35 per pill), and doctors say more research must be done on the pill, which is known as PrEP.

For more, visit HIV Plus.